medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2013, Number 607

<< Back Next >>

Rev Med Cos Cen 2013; 70 (607)

Cáncer de Mama: Características Anatomopatológicas

Brenes FMA, Brenes FJ, Núñez RC

Language: Spanish
References: 27
Page: 395-399
PDF size: 209.22 Kb.


ABSTRACT

Breast cancer is a heterogeneous and multifactorial disease in both levels, clinical and pathological. It results from a series of cellular events that produce an abnormally disordered growth of epithelial cells of the mammary ducts and lobules. Worldwide breast cancer is the most frequently diagnosed malignancy among Western women and represents a real public health problem. This review was made in order to update the knowledge about breast cancer as a disease that is constantly evolving and a health problem that does not escape from primary care.


REFERENCES

  1. Agency for Research on Cancer (IARC). Globocan International 2008. [consultado el 17/2/2012 a las 6:00p m.]. Disponible en: http://globocan.iarc fr/.

  2. Agudelo B M. Niveles, tendencia e impacto de la mortalidad por cáncer de mama en Costa Rica según provincias, 2000-2009. Población y Salud en Mesoamérica. Vol 9, Nº 1, art 4, jul-dic 20011. Pp 1-14.

  3. American Cancer Society. Breast Cancer Facts & figures 2011-2012. Atlanta: American Cancer Society, Inc. p. 1-8. Disponible en: www.cancer.org

  4. American Cancer Society. Datos y Estadísticas sobre el Cáncer entre los Hispanos/Latinos 2009-2011. Atlanta: American Cancer Society, Inc. 2009. Archivo pdf. p. 2 [consultado el 24 de febrero del 2012, 5:00 a m.] Disponible en: www.cancer.org/statistics

  5. Aparicio LI A, Morera SM. Patrones geográficos de incidencia y mortalidad evitable por cáncer de mama en Costa Rica. Rev Costarr Salud Pública 2009. Vol 18, No1-enero-julio 2009. Pp 43-47.

  6. Blows FM, et al. Subtyping of breast cancer by Immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLOS med 2010; 7(5): e 1000279

  7. Burstein HJ, Harris JR and Morrow M. Malignant Tumors on the breast. In: de Vita, Hellman, Rosemberg, and editors. Cancer: Principles & Practice of Oncology. 8a Ed. Philadelphia: Lippincott-Williams. pp. 1606-1654; 2008.

  8. Del Casar JM, et al. Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinic pathological characteristics, biological features and prognosis. Eur J Obstet Gynecol Reprod Biol 2008; 141(2): 147-52.

  9. Fauci SA, et al. Harrison. Principios de Medicina Interna, 17ma edición. Editorial Mc Graw Hill, México, 2009. Cap. 86, pp.: 563-570.

  10. Fitzgibbons PL, Page DL, Weaver D y cols. Prognostic factors in breast cancer. College of American Pathologists. Consensus Statement 1999. Arch Pathol Lab Med 1999; 124: 966-78

  11. GAMO. Tercera revisión de Consenso Nacional sobre diagnóstico y tratamiento del cáncer de mama. 2008; 7 (supl 6), p7.

  12. Gómez A., Rodríguez CA. Cáncer de mama. En JJ Cruz Hernández, CA Rodríguez, E del Barco, editores: Oncología Clínica, 4a Ed. Editorial Nova Sidonia. Madrid, España. 2008, pp. 338-369.

  13. Michaelson JS, et al. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer 2003; 98(10):2133-43.

  14. Millar EK, et al. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in earlystage invasive breast cancer using a fivebiomarker panel. J Clin Oncol 2009; 27(28):4701-8.

  15. Millikan RC, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008; 109 (1): 123-39.

  16. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ®. Breast Cancer. Versión 1. 2012. NCCN. org [consultado el 15 abril 2012, 16 hrs]. Dispoble en: http: //www nccn.org/ professionals/physician_gls/pdf/breast. pdf.

  17. Nielsen TO, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004; 10(16): 5367-74

  18. Organización Mundial de la Salud. Cáncer. Centro de prensa, Nota descriptiva N° 297, febrero de 2012, WHO [consulta el 17 de feb. de 12. 8:45]. Disponible en: http://www.who. int/mediacentre/factsheets/fs297/es/ index.html.

  19. Organización Mundial de la Salud. Cancer mortality and morbidity, Global Health Observatory (GHO), WHO. [consultado el 17 de feb. de 12, 8:39]. Disponible en: http://www.who.int/gho/ ncd/mortality_morbidity/cancer/en/ index html.

  20. Ortiz B A, Vargas AR, Muñoz LG. Incidencia y Mortalidad del Cáncer en Costa Rica 1990-2003. Ministerio de Salud, San José – Costa Rica, julio 2005.

  21. Parker JS, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009; 27(8):1160- 7.

  22. Perou CM, et al. Molecular portraits of human breast tumors. Nature 2000; 406(6797): 747-52.

  23. Rakha EA, Ellis IO. Triple-negative/ basal-like breast cancer: review. Pathology 2009; 41:40-47.

  24. Rosen, PP. Rosen’s breast pathology, 2da edition, 2001. Editorial Lippincott Williams and Wilkins, USA. Cap 14, pp.: 325-356.

  25. Sorlie T, et al. Predictors of satisfaction with surgical treatment. Int J Qual Health Care 2000; 12(1): 31-40.

  26. Tavassoli FA, Devilee P, Eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press, Lyon 2003.

  27. Voduc KD, et al. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol; 28(10): 1684-91.




2020     |     www.medigraphic.com